Publication

Clinical advances in musculoskeletal imaging: spondylodiscitis and pediatric oncology

Kasalak, Ö. 2019 [Groningen]: University of Groningen. 175 p.

Research output: ThesisThesis fully internal (DIV)

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 53 KB, PDF-document

  • Chapter 1

    Final publisher's version, 118 KB, PDF-document

  • Chapter 2

    Final publisher's version, 1 MB, PDF-document

  • Chapter 3

    Final publisher's version, 437 KB, PDF-document

  • Chapter 4

    Final publisher's version, 1 MB, PDF-document

    Embargo ends: 23/01/2020

  • Chapter 5

    Final publisher's version, 2 MB, PDF-document

    Embargo ends: 01/09/2019

  • Chapter 6

    Final publisher's version, 1 MB, PDF-document

  • Chapter 7

    Final publisher's version, 694 KB, PDF-document

  • Chapter 8

    Final publisher's version, 670 KB, PDF-document

    Embargo ends: 11/05/2019

  • Chapter 9

    Final publisher's version, 423 KB, PDF-document

  • Chapter 10

    Final publisher's version, 175 KB, PDF-document

  • Chapter 11

    Final publisher's version, 176 KB, PDF-document

  • Complete thesis

    Final publisher's version, 6 MB, PDF-document

    Embargo ends: 23/01/2020

  • Propositions

    Final publisher's version, 22 KB, PDF-document

This thesis focused on two subjects in the field of musculoskeletal imaging: spondylodiscitis and bone tumors in children. Clinical imaging data were analyzed and correlated with patient characteristics, laboratory values, pathological results, and follow-up.
We found that in patients with a suspicion of spondylodiscitis on MRI, the culture yield of CT-guided biopsy was rather low: only one out of three biopsies was positive for a certain micro-organism, both for the initial and repeat biopsy. Moreover, more than 95% of patients with suspected spondylodiscitis would have been adequately treated with empiric antibiotics, regardless of the biopsy result (excluding immunocompromised patients). This questions the need for routine CT-guided biopsy in these patients.
In children with bone tumors, we found that two MRI findings are helpful in differentiating Ewing sarcoma from osteomyelitis, namely the presence of a soft-tissue mass and a sharp transition zone from pathologic to normal bone. Furthermore, a CT-guided biopsy of a bone lesion in a child with an indeterminate result of pathologic examination virtually always proved to indicate benignancy. Finally, in Ewing sarcoma, tumor volume measurements are subject to some degree of observer variability but this does not affect prognostic stratification, FDG-PET/CT may potentially replace invasive bone marrow biopsy for staging, and surveillance MRI after completion of treatment proved to be futile. These findings can improve the use of imaging and CT-guided biopsy for diagnosis, staging, follow-up and consultation of patients (and their parents) with bone tumors and Ewing sarcoma in particular.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
  • Dierckx, Rudi, Supervisor
  • Kwee, Thomas, Co-supervisor
  • Jutte, Paulus Christiaan, Co-supervisor, External person
  • Bulstra, Sjoerd, Assessment committee
  • van Kuijck, C., Assessment committee, External person
  • Verstraete, K. (Koenraad), Assessment committee, External person
Award date23-Jan-2019
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-6323-491-7
Electronic ISBNs978-94-034-1412-6
StatePublished - 2019

View graph of relations

Download statistics

No data available

ID: 73985942